The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death

Cell Cycle

Volumn 10, Issue 23, 2011, Pages 4119-4127

  McGee, Allison M ^a   Douglas, Diana L ^a   Liang, Yayun ^a   Hyder, Salman M ^a,b   Baines, Christopher P ^a,b,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

Author keywords

Cell death; Cell migration; Cell proliferation; Mitochondria; Tumor cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q BINDING PROTEIN; DOXORUBICIN; MITOCHONDRIAL PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER PATIENT; CARCINOGENESIS; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; GENE FUNCTION; GENE GAIN; GENE LOSS; HUMAN; HUMAN CELL; LUNG CANCER; RNA INTERFERENCE;

EID: 82855170860     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.23.18287     Document Type: Article

References (35)

1. Storrs SB, Kolb WP, Pinckard RN, Olson MS. Characterization of the binding of purified human C1q to heart mitochondrial membranes. J Biol Chem 1981; 256:10924-9; PMID:6974732.
2. Ghebrehiwet B, Lim BL, Kumar R, Feng X, Peerschke EI. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol Rev 2001; 180:65-77; PMID:11414365; DOI:10.1034/ j.1600-065X.2001.1800106.x.
3. Peerschke EI, Petrovan RJ, Ghebrehiwet B, Ruf W. Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation. Thromb Haemost 2004; 92:811-9; PMID:15467913.
4. McGee AM, Baines CP. Complement 1q-binding protein inhibits the mitochondrial permeability transition pore and protects against oxidative stress-induced death. Biochem J 2011; 433:119-25; PMID:20950273; DOI:10.1042/BJ20101431.
5. Dedio J, Jahnen-Dechent W, Bachmann M, Müller- Esterl W. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol 1998; 160:3534-42; PMID:9531316.
6. Muta T, Kang D, Kitajima S, Fujiwara T, Hamasaki N. p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem 1997; 272:24363-70; PMID:9305894; DOI:10.1074/jbc.272.39.24363.
7. Seytter T, Lottspeich F, Neupert W, Schwarz E. Mam33p, an oligomeric, acidic protein in the mitochondrial matrix of Saccharomyces cerevisiae is related to the human complement receptor gC1q-R. Yeast 1998; 14:303-10; PMID:9559539; DOI:10.1002/ (SICI)1097-0061(19980315)14:4〈303:: AIDYEA217〉 3.0.CO;2-N.
8. Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 2010; 30:1303-18; PMID:20100866; DOI:10.1128/MCB.01101-09.
9. Solaini G, Sgarbi G, Baracca A. Oxidative phosphorylation in cancer cells. Biochim Biophys Acta 2011; 1807:534-42; PMID:20849810; DOI:10.1016/j.bbabio. 2010.09.003.
10. Kaipparettu BA, Ma Y, Wong LJ. Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann NY Acad Sci 2010; 1201:137-46; PMID:20649550; DOI:10.1111/j.1749-6632.2010. 05621.x.
11. Rubinstein DB, Stortchevoi A, Boosalis M, Ashfaq R, Ghebrehiwet B, Peerschke EI, et al. Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan- binding protein) is preferentially expressed by adenocarcinoma cells. Int J Cancer 2004; 110:741-50; PMID:15146564; DOI:10.1002/ijc.20105.
12. Fogal V, Zhang L, Krajewski S, Ruoslahti E. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res 2008; 68:7210-8; PMID:18757437; DOI:10.1158/0008-5472.CAN-07-6752.
13. Chen YB, Jiang CT, Zhang GQ, Wang JS, Pang D. Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer. J Surg Oncol 2009; 100:382-6; PMID:19565630; DOI:10.1002/jso.21329.
14. Amamoto R, Yagi M, Song Y, Oda Y, Tsuneyoshi M, Naito S, et al. Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy. Cancer Sci 2011; 102:639-47; PMID:21205079; DOI:10.1111/j.1349- 7006.2010.01828.x.
15. Sunayama J, Ando Y, Itoh N, Tomiyama A, Sakurada K, Sugiyama A, et al. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32. Cell Death Differ 2004; 11:771-81; PMID:15031724; DOI:10.1038/sj.cdd.4401418.
16. Kamal A, Datta K. Upregulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with Cisplatin induced apoptosis. Apoptosis 2006; 11:861- 74; PMID:16544101; DOI:10.1007/s10495-006- 5396-4.
17. Chowdhury AR, Ghosh I, Datta K. Excessive reactive oxygen species induces apoptosis in fibroblasts: role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR). Exp Cell Res 2008; 314:651-67; PMID:18166172; DOI:10.1016/j. yexcr.2007.10.033.
18. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727-30; PMID:11326099; DOI:10.1126/science.1059108.
19. Sanchez-Martin D, Cuesta AM, Fogal V, Ruoslahti E, Alvarez-Vallina L. The multicompartmental p32/ gClqR as a new target for antibody-based tumor targeting strategies. J Biol Chem 2011; 286:5197-203; PMID:21156793; DOI:10.1074/jbc.M110.161927.
20. Jung K, Reszka R. Mitochondria as subcellular targets for clinically useful anthracyclines. Adv Drug Deliv Rev 2001; 49:87-105; PMID:11377805; DOI:10.1016/ S0169-409X(01)00128-4.
21. Munoz-Gamez JA, Martin-Oliva D, Aguilar-Quesada R, Canuelo A, Nunez MI, Valenzuela MT, et al. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem J 2005; 386:119-25; PMID:15456408; DOI:10.1042/ BJ20040776.
22. Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Cancer Lett 2007; 258:181-8; PMID:17920763; DOI:10.1016/j.canlet.2007.08.019.
23. Itahana K, Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 2008; 13:542-53; PMID:18538737; DOI:10.1016/j. ccr.2008.04.002.
24. Seo M, Lee WH, Suk K. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J 2010; 24:464-78; PMID:19812375; DOI:10.1096/fj.09-137562.
25. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Krasmediated tumorigenicity. Proc Natl Acad Sci USA 2010; 107:8788-93; PMID:20421486; DOI:10.1073/ pnas.1003428107.
26. Hole PS, Pearn L, Tonks AJ, James PE, Burnett AK, Darley RL, et al. Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34+ hematopoietic progenitor cells. Blood 2010; 115:1238-46; PMID:20007804; DOI:10.1182/ blood-2009-06-222869.
27. Comito G, Calvani M, Giannoni E, Bianchini F, Calorini L, Torre E, et al. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med 2011; 51:893- 904; PMID:21703345; DOI:10.1016/j.freeradbiomed. 2011.05.042.
28. Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, Sgroi D, et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci USA 2010; 107:4675-80; PMID:20176937; DOI:10.1073/ pnas.0907705107.
29. Pelicano H, Lu W, Zhou Y, Zhang W, Chen Z, Hu Y, et al. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 2009; 69:2375-83; PMID:19276362; DOI:10.1158/0008-5472.CAN-08-3359.
30. Chang CJ, Yin PH, Yang DM, Wang CH, Hung WY, Chi CW, et al. Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells. Cell Mol Life Sci 2009; 66:1755-65; PMID:19337692; DOI:10.1007/ s00018-009-8767-5.
31. Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK, et al. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 2008; 29:1742-50; PMID:18632752; DOI:10.1093/carcin/bgn167.
32. Sengupta A, Banerjee B, Tyagi RK, Datta K. Golgi localization and dynamics of hyaluronan binding protein 1 (HABP1/p32/C1QBP) during the cell cycle. Cell Res 2005; 15:183-6; PMID:15780180; DOI:10.1038/ sj.cr.7290284.
33. van Leeuwen HC, O'Hare P. Retargeting of the mitochondrial protein p32/gC1Qr to a cytoplasmic compartment and the cell surface. J Cell Sci 2001; 114:2115-23; PMID:11493647.
34. Chattopadhyay C, Hawke D, Kobayashi R, Maity SN. Human p32 interacts with B subunit of the CCAATbinding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro. Nucleic Acids Res 2004; 32:3632-41; PMID:15243141; DOI:10.1093/nar/gkh692.
35. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434:658-62; PMID:15800627; DOI:10.1038/nature03434.